These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 1967277

  • 21. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
    Nakamura T, Takahashi K, Fukazawa T, Koyanagi M, Yokoyama A, Kato H, Yagita H, Okumura K.
    J Immunol; 1990 Dec 01; 145(11):3628-34. PubMed ID: 1700989
    [Abstract] [Full Text] [Related]

  • 22. CD44 contributes to T cell activation.
    Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A.
    J Immunol; 1989 Aug 01; 143(3):798-801. PubMed ID: 2568380
    [Abstract] [Full Text] [Related]

  • 23. Human cytotoxic effector cells: definition and analysis of activity.
    Ortaldo JR.
    Allergol Immunopathol (Madr); 1991 Aug 01; 19(4):145-56. PubMed ID: 1726345
    [Abstract] [Full Text] [Related]

  • 24. Lymphokine-activated killing by human intestinal lymphocytes.
    Ebert EC, Roberts AI.
    Cell Immunol; 1993 Jan 01; 146(1):107-16. PubMed ID: 7678783
    [Abstract] [Full Text] [Related]

  • 25. Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells.
    Sugita K, Robertson MJ, Torimoto Y, Ritz J, Schlossman SF, Morimoto C.
    J Immunol; 1992 Aug 15; 149(4):1199-203. PubMed ID: 1354231
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
    Ochoa AC, Hasz DE, Rezonzew R, Anderson PM, Bach FH.
    Cancer Res; 1989 Feb 15; 49(4):963-8. PubMed ID: 2521457
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interleukin 2 up-regulates its own production.
    Hu J, Vaquero C, Huet S, Bernard A, Sterkers G.
    J Immunol; 1987 Dec 15; 139(12):4109-15. PubMed ID: 3121730
    [Abstract] [Full Text] [Related]

  • 31. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J, Gulati SC.
    Stem Cells; 1993 Nov 01; 11(6):511-8. PubMed ID: 8111310
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD, Economou JS, Shau H, Golub SH.
    J Surg Res; 1993 Nov 01; 55(5):486-92. PubMed ID: 8231167
    [Abstract] [Full Text] [Related]

  • 38. Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules.
    Huet S, Boumsell L, Raynal B, Degos L, Dausset J, Bernard A.
    Proc Natl Acad Sci U S A; 1987 Oct 01; 84(20):7222-6. PubMed ID: 3118361
    [Abstract] [Full Text] [Related]

  • 39. IL-10: a novel cytotoxic T cell differentiation factor.
    Chen WF, Zlotnik A.
    J Immunol; 1991 Jul 15; 147(2):528-34. PubMed ID: 1906502
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.